miércoles, 19 de noviembre de 2014

NCTR Publications > NCTR Research Highlights

NCTR Publications > NCTR Research Highlights

National Center for Toxicological Researh log with FDA on left side

Current Highlight from November 14, 2014

Progress on FDA Studies Reviewed
The 44th meeting of the Toxicology Study Selection and Review Committee (TSSRC) was held November 12-13, 2014, at FDA’s White Oak facility, to discuss ongoing studies that are part of the Interagency Agreement between FDA/NCTR and the National Institute of Environmental Health Sciences/National Toxicology Program (NIEHS/NTP) that supports toxicology studies providing data for the FDA risk assessment process.
Ongoing studies at NCTR in the following areas were discussed:
  • Food contaminants (Bisphenol A; melamine + cyanuric acid; nanosilver)
  • Topically applied compounds (retinyl palmitate; oxybenzone)
  • Antibacterial chemicals (triclosan)
  • Medical device components (nanosilver)
  • Dietary supplement component (aloe vera)
The NIEHS/NTP presented updates on the NTP and the NIEHS/NTP Toxicology Testing Program. 
The TSSRC is comprised of regulatory scientists and subject-matter experts from the FDA Centers (CBER, CDER, CDRH, CFSAN, CVM, and CTP), NIEHS/NTP, and the National Institutes of Health.  The committee meets twice each year and is responsible for scientific oversight of study design and progress of ongoing work under this Interagency Agreement.  The next meeting of the TSSRC will be held at the FDA White Oak campus, May 6-7, 2015. 
For additional information, please contact Paul C. Howard, Ph.D., Director, Office of Scientific Coordination, FDA/NCTR.

Contact FDA

National Center for Toxicological Research

Food and Drug Administration
3900 NCTR Road
Jefferson, AR 72079

No hay comentarios:

Publicar un comentario